RGRichard P. Gerraty

Richard P. Gerraty

*This is an algorithmically generated author record based on publicly available information.

Richard P. Gerraty has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Framingham Risk Score Prediction at 12 Months in the STANDFIRM Randomized Control Trial

    by Thanh G. Phan, Velandai K. Srikanth, Dominique A. Cadilhac, Mark Nelson, Joosup Kim, Muideen T. Olaiya, Sharyn M. Fitzgerald, Christopher Bladin, Richard Gerraty, Henry Ma, et al.

    Background: The STANDFIRM (Shared Team Approach Between Nurses and Doctors for Improved Risk Factor Management; ANZCTR registration ACTRN12608000166370) trial was designed to test the effectiveness of chronic disease care management for modifying the Framingham risk score (FRS) among patients with stroke or transient ischemic attack. The primary outcome of change in FRS was not met. We determine baseline characteristics that predict reduction in FRS at 12 months and whether future FRS is predetermined at baseline. Methods and Results: We used machine learning regression methods to evaluate 35 variables encompassing demographics, risk factors, psychological, social and education status, and laboratory tests. We determine the optimal machine learning and associated tuning parameters from the following: random forest, extreme gradient boosting, category boosting, support vector regression, multilayer perceptron neural network, and K‐nearest neighbor. Training (n=404) and test (n=103) data were evenly matched for age, sex, baseline, and 12‐month FRS. The optimal model for predicting FRS at 12 months was category boosting ( R 2 =0.712; root mean square error, 7.32). The 5 variables with highest Shapley values for category boosting were baseline FRS (Shapley additive explanation [SHAP], 8.42 of total of 12.12), age (SHAP, 1.58), systolic blood pressure (SHAP, 0.23), male sex (SHAP, 1.05), and London Handicap (SHAP, 0.18). Machine learning methods were poor at determining change in FRS at 12 months ( R 2 <0.22). Conclusions: Our findings suggest that change in FRS as an end point in secondary stroke trials may have limited value as it is largely determined at baseline. In this cohort, category boosting was the optimal method to predict future FRS but not change in FRS.


  • Author reply to Prentice: “Acute vestibular neuritis may provoke atrial fibrillation”

    by Adam G. Mirabelli, Ronald Dick, Bernard Infeld, Richard P. Gerraty

  • Juvenile muscular atrophy of the distal upper extremity (Hirayama syndrome): a systematic review

    by Henrik C. Bäcker, Jacob Bock, Peter Turner, Michael A. Johnson, John Cunningham, Patrick Chan, Richard Gerraty

    Introduction Hirayama syndrome is likely caused by a forward displacement of the posterior dura during cervical flexion leading to changes in the muscles of the fingers and wrist. The aim of this systematic review was to document the number of reported cases, the necessity of dynamic MRI of the cervical spine and the subsequent treatment. Methods and materials A systematic review was conducted and the Pubmed/Medbase, Cochrane, Google, Embase and Ovid database were searched for (Hirayama) AND ((disease) OR (syndrome)). A total of 42 studies were included for analysis reporting 2311 patients. Results The mean age was 20.2 ± 2.26 years and predominantly males (92.8%) were identified. On MRI the “snake eyes” appearance of the spinal cord was present in 27.8% and the typical time between onset of symptoms and diagnosis was 41.5 ± 16.4 months. A variety of different treatments have been reported, although there is no substantial evidence that any of them are superior to observation. Conclusion The delay in diagnosis from initial presentation of symptoms shows that this condition may be underdiagnosed in a variety of cases. Further, this study shows the necessity of either a dynamic MRI in flexion or a static MRI scan in neutral position and in flexion, to identify functional spinal and/or foraminal stenosis for a prompt diagnosis and subsequent treatment.


  • Open Access

    Acute vestibular neuritis may provoke atrial fibrillation

    by Adam G. Mirabelli, Ronald Dick, Bernard Infeld, Richard P. Gerraty

    Background: Exclusion of stroke is the focus of guidelines in the emergency department assessment of acute vertigo, especially with new‐onset atrial fibrillation (AF). Early diagnosis of vestibular neuritis (VN) is also important but may be deferred awaiting brain magnetic resonance imaging (MRI) for exclusion of stroke. This may delay potentially beneficial corticosteroid therapy.Aims: To highlight that VN can provoke acute AF.Methods: In the course of a prospective study of acute vertigo in patients assessable within 24 h of admission, we encountered three patients with acute onset transient AF associated with VN. We performed a detailed neurological examination and quantitated the vestibulo‐ocular reflex (VOR) gain with video‐oculography. Brain MRI was performed in all patients.Results: There were two men and one woman, aged 58–66 (mean 61) years. All patients had typical non‐direction‐changing rotatory nystagmus and positive head impulse tests. The horizontal VOR gains ranged 0.38–0.62 (mean 0.47). Diffusion‐weighted MRI within 36 h was normal in all. AF reverted in all three within 24 h.Conclusions: Acute AF can be precipitated by vertigo such as in VN. In VN, the concurrence of acute AF may distract from the correct neurological diagnosis, delaying potentially beneficial corticosteroid therapy, especially if exclusion of stroke is dependent on MRI, which may be delayed.


  • Open Access

    Connections: neurology beyond neuroscience

    by Richard Gerraty

  • Abstract P375: Using a Recalibrated Cardiovascular Disease Risk Score is Not Adequate to Predict Risk of Recurrence Within 3 Years in Australian Survivors of Stroke

    by David Ung, Richard P Gerraty, Judith Frayne, Muideen T Olaiya, Joosup Kim, Velandai K Srikanth, Thanh Phan, Dominique A Cadilhac, Mark R Nelson, Christopher F Bladin, et al.

    Background: Prognostic performances of models predicting risk of recurrent events of cardiovascular disease (CVD) are not adequate for use in clinical settings. We aimed to determine whether adapting the Framingham Risk Score (FRS) to an Australian population could effectively predict recurrent cardiovascular outcomes. Methods: Patients comprised survivors of stroke/TIA who participated in the Shared Team Approach between Nurses and Doctors For Improved Risk factor Management (STAND FIRM) trial (n = 563). We used standardised anthropometric, biochemical and blood pressure data, collected at baseline, to evaluate risk factors for stroke/TIA. Cox proportional hazards regression models were used to determine the risk of recurrence of CVD-related events and deaths within 3 years after stroke/TIA; adjudicated by two independent stroke specialists. Regression estimates were then used to recalibrate the coefficients used by the FRS, and performance of the model assessed. Results: In women, the recalibrated FRS model had poor discrimination (C-statistic = 0.634) and appeared to better predict CVD recurrence (AUC = 0.664) than the original FRS model (AUC = 0.598). However in men, the recalibrated FRS model had poor discrimination (C-statistic = 0.604) and prediction of CVD recurrence (AUC = 0.632) similar to the original FRS model (AUC = 0.606). Conclusion: The original FRS and recalibrated FRS models appeared to perform poorly in Australian men and women with stroke. The identification of relevant risk factors, easily measured in a clinical setting, may help clinicians better monitor the risks of their patients and enhance secondary prevention strategies.

  • Abstract P147: Longer Duration on a Chronic Disease Management Plan is Associated with Fewer CVD-Related Readmissions by 3 Years Among Australian Survivors of Stroke

    by David Ung, Richard P Gerraty, Judith Frayne, Muideen T Olaiya, Joosup Kim, Velandai K Srikanth, Thanh Phan, Dominique A Cadilhac, Mark R Nelson, Christopher F Bladin, et al.

    Background: Chronic Disease Management (CDM) plans are usually administered by general practitioners (GPs) to assist those with a chronic medical condition, such as stroke, and provide better management of risk factors. Despite the prevalent use of CDM plans, its comprehensiveness and the fact that there is a government commitment to fund it, there is limited evidence of its effectiveness in Australian survivors of stroke. We aimed to assess the effectiveness of CDM plans on preventing the recurrence of CVD-related serious adverse events. Methods: Patients comprised survivors of stroke/TIA who participated in the Shared Team Approach between Nurses and Doctors For Improved Risk factor Management (STAND FIRM) trial (n = 563). We used standardised anthropometric, biochemical and blood pressure data, collected at baseline, to evaluate risk factors for stroke/TIA. Poisson regression models were used to determine the incidence rate ratio (IRRs) of increasing exposure to being on a CDM plan over 3 years, while adjusting for confounding factors. We used the total count of CVD-related events and deaths within 3 years after stroke/TIA, based on either hospital discharge codes or adjudication by two independent stroke specialists. Results: Five hundred and sixty-three patients were included (median age 70; 36% female). There were 305 CVD-related events over the three years (mean 0.54), in which a third (104) were adjudicated and two-thirds (201) were derived from hospital discharge codes alone. Nearly a quarter (27%) did not take up a CDM plan over the three years, a third (33%) were on plans for less than 1.5 years and 40% were on plans from 1.5 years to 3 years. The factors most strongly associated with decreased incidence of CVD-related events were duration on a CDM plan (Adjusted IRR (aIRR) 0.85, 95% confidence interval (95%CI) 0.77-0.93; pConclusion: Being on a CDM plan for a longer duration appeared to reduce the occurrence of CVD-related events within 3 years after stroke, potentially via more closely controlled risk factors. Patients should be encouraged to return for regular reviews of their CDM plans to enhance secondary prevention strategies, and maintain a better quality of life.

  • Abstract TP396: Accuracy of Administrative Hospital, Emergency Department and Death Records

    by David Ung, Richard P Gerraty, Judith Frayne, Muideen T Olaiya, Joosup Kim, Velandai K Srikanth, Thanh Phan, Dominique A Cadilhac, Mark R Nelson, Christopher F Bladin, et al.

    Background: Hospital, emergency presentation and death databases are frequently used to research outcomes after stroke. The reliability of diagnostic coding for cardiovascular disease (CVD) in these administrative data remains uncertain. We aimed to determine the reliability of these data in Australia using an existing clinical trial cohort. Methods: Patients with stroke/TIA who participated in the Shared Team Approach between Nurses and Doctors For Improved Risk factor Management (STAND FIRM) trial (n = 563, recruited from 4 hospitals within Victoria). We used diagnostic ICD-10-AM coded data from hospital, emergency department and death databases within 2 years after stroke/TIA. Medical records for these potential CVD-related events were reviewed by two independent stroke specialists and adjudicated according to strict criteria. We then estimated sensitivity and specificity of using either primary or both primary and secondary diagnoses fields (obtained for all adjudicated records), against the events adjudicated by the specialists (gold standard). False positives were CVD-events defined by ICD-10-AM diagnostic codes that were adjudicated as not being a CVD-event. False negatives were true CVD-events that were misclassified as not being CVD-related when using ICD-10-AM codes. Results: We identified 261 events for medical review. After adjudication, 65 were classified as CVD-events (cases) and 196 were not CVD-events. Using both primary and secondary diagnoses, 55 true positives were correctly identified among the cases (sensitivity = 84.6%) and 129 true negatives among the non-cases (specificity = 65.8%). Using only primary diagnoses, 48 true positives were identified (sensitivity = 73.9%) and 171 true negatives (specificity = 87.2%). Using both primary and secondary diagnoses had an increased sensitivity, but decreased specificity (area under the Receiver Operating Characteristic curve (AUC) = 0.75; 95% CI, 0.70, 0.81) when compared with using only primary diagnoses (AUC = 0.81; 95% CI, 0.75, 0.86; p = 0.028). Conclusion: Both primary and secondary diagnoses should be used to identify true CVD-events and minimise misclassifying these in administrative databases.

  • Open Access

    Development of a theory-informed implementation intervention to improve the triage, treatment and transfer of stroke patients in emergency departments using the Theoretical Domains Framework (TDF): the T3 Trial

    by Louise E. Craig, Natalie Taylor, Rohan Grimley, Dominique A. Cadilhac, Elizabeth McInnes, Rosemary Phillips, Simeon Dale, Denise O’cOnnor, Chris Levi, Mark Fitzgerald, et al.

    Theoretical frameworks and models based on behaviour change theories are increasingly used in the development of implementation interventions. Development of an implementation intervention is often based on the available evidence base and practical issues, i.e. feasibility and acceptability. The aim of this study was to describe the development of an implementation intervention for the T3 Trial (Triage, Treatment and Transfer of patients with stroke in emergency departments (EDs)) using theory to recommend behaviour change techniques (BCTs) and drawing on the research evidence base and practical issues of feasibility and acceptability. A stepped method for developing complex interventions based on theory, evidence and practical issues was adapted using the following steps: (1) Who needs to do what, differently? (2) Using a theoretical framework, which barriers and enablers need to be addressed? (3) Which intervention components (behaviour change techniques and mode(s) of delivery) could overcome the modifiable barriers and enhance the enablers? A researcher panel was convened to review the list of BCTs recommended for use and to identify the most feasible and acceptable techniques to adopt. Seventy-six barriers were reported by hospital staff who attended the workshops (step 1: thirteen TDF domains likely to influence the implementation of the T3 Trial clinical intervention were identified by the researchers; step 2: the researcher panellists then selected one third of the BCTs recommended for use as appropriate for the clinical context of the ED and, using the enabler workshop data, devised enabling strategies for each of the selected BCTs; and step 3: the final implementation intervention consisted of 27 BCTs). The TDF was successfully applied in all steps of developing an implementation intervention for the T3 Trial clinical intervention. The use of researcher panel opinion was an essential part of the BCT selection process to incorporate both research evidence and expert judgment. It is recommended that this stepped approach (theory, evidence and practical issues of feasibility and acceptability) is used to develop highly reportable implementation interventions. The classifying of BCTs using recognised implementation intervention components will facilitate generalisability and sharing across different conditions and clinical settings.